NCT00425516View on ClinicalTrials.gov

Breast Cancer Treated by Neoadjuvant Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Individualized Chemotherapy
Interventions
DRUG

Taxotere

DRUG

5-Fluorouracil

DRUG

Epirubicin

DRUG

Cyclophosphamide

Trial Locations (6)

19100

Hospital center, Brive-la-Gaillarde

38043

University Hospital La Tronche, Grenoble

42270

Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez

51056

Institut Jean Godinot, Reims

63011

Centre Jean Perrin, Clermont-Ferrand

69000

Edouard Herriot University Hospital, Lyon

All Listed Sponsors
lead

Centre Jean Perrin

OTHER

NCT00425516 - Breast Cancer Treated by Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter